Edition:
India

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

14.70USD
13 Dec 2017
Change (% chg)

$0.10 (+0.68%)
Prev Close
$14.60
Open
$14.60
Day's High
$15.00
Day's Low
$14.50
Volume
99,317
Avg. Vol
49,952
52-wk High
$23.00
52-wk Low
$11.80

Latest Key Developments (Source: Significant Developments)

Morgan Stanley Reports 5 Pct Passive Stake In Atara Biotherapeutics As Of Nov 27
Friday, 8 Dec 2017 

Dec 7 (Reuters) - Atara Biotherapeutics Inc ::MORGAN STANLEY REPORTS 5.0 PERCENT PASSIVE STAKE IN ATARA BIOTHERAPEUTICS INC AS OF NOVEMBER 27 - SEC FILING.  Full Article

Atara Biotherapeutics reports Q3 loss per share $1.02
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Atara Biotherapeutics Inc :Atara Biotherapeutics Inc announces third quarter 2017 financial results and recent highlights.Q3 loss per share $1.02.Q3 earnings per share view $-0.98 -- Thomson Reuters I/B/E/S.Atara Biotherapeutics Inc - ‍cash, cash equivalents and short-term investments as of Sept 30, 2017 totaled $200.2 million.Atara Biotherapeutics Inc - ‍cash, cash equivalents and short-term investments will be sufficient to fund planned operations into Q1 2019​.  Full Article

Atara Biotherapeutics announces abstract publication for two MSParis2017 congress presentations
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Atara Biotherapeutics Inc :Atara Biotherapeutics announces abstract publication for two MSParis2017 congress presentations, including updated interim results from a phase 1 study of autologous ATA190 in patients with progressive multiple sclerosis (MS).Atara Biotherapeutics Inc - ‍no significant adverse events have been observed in study​.  Full Article

Atara Biotherapeutics reports Q2 loss per share $0.66
Monday, 8 Aug 2016 

Atara Biotherapeutics Inc : Atara bio announces second quarter 2016 financial results and recent highlights . Q2 loss per share $0.66 . Q2 earnings per share view $-0.61 -- Thomson Reuters I/B/E/S .Cash, investments as of June 30 totaled $294.6 million, which co believes to be sufficient to fund planned operations through 2018.  Full Article

BRIEF-Morgan Stanley Reports 5 Pct Passive Stake In Atara Biotherapeutics As Of Nov 27

* MORGAN STANLEY REPORTS 5.0 PERCENT PASSIVE STAKE IN ATARA BIOTHERAPEUTICS INC AS OF NOVEMBER 27 - SEC FILING Source text: (http://bit.ly/2jrEZiq) Further company coverage: